Skip to main content
Caplight Logo









HumanTouch Surgical

HumanTouch Surgical

Private
NetanyaHealthcare & Life Scienceshttps://human-x.com/

Last Round

IPO

Nov 29, 2020

Est. Valuation

$208M

Company Overview

HumanTouch Surgical is a medical robotics company that develops software-driven, handheld surgical devices designed to enhance minimally invasive surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical roboticsminimally invasive surgerylaparoscopic surgeryrobotic-assisted surgerysurgical instrumentshandheld surgical devicedigital surgerysurgical roboticslaparoscopymedical device manufacturerarticulated instrumentssingle-use instrumentsMISrobot-assisted laparoscopysurgical tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HumanTouch Surgical Comparables

Compare HumanTouch Surgical with similar companies based on industry and business-model similarity.

HumanTouch Surgical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
US Medical Innovations
81%
Distalmotion
80%
Moon Surgical
78%

HumanTouch Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPONov 29, 2020
VC RoundSep 1, 2019
VC RoundJul 1, 2017

HumanTouch Surgical Investors

Notable investors and investment history

HumanTouch Surgical investors
InvestorRounds
Psagot Investment HouseVC Round
I.B.I. - Managing & Underwriting Ltd.VC Round
Infinity GroupVC Round
DNV CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 41% MoM.

  • Sep 1, 2019

    $10M raised from Psagot Investment House and DNV Capital.

HumanTouch Surgical Filings

Explore SEC and related filing metadata, where available.

HumanTouch Surgical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HumanTouch Surgical's valuation, stock price, and market status.

Is HumanTouch Surgical a public or private company?

HumanTouch Surgical is a private company.

What is the current stock price of HumanTouch Surgical?

HumanTouch Surgical is a private company with no public stock price. No recent secondary market data is available.

How much is HumanTouch Surgical worth (valuation)?

HumanTouch Surgical's valuation is estimated at $208.0M based on funding round data.

Can I buy HumanTouch Surgical stock?

HumanTouch Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HumanTouch Surgical's last funding round?

HumanTouch Surgical's most recent funding round was IPO on November 29, 2020.

Who are the main investors in HumanTouch Surgical?

Key investors in HumanTouch Surgical include Psagot Investment House, I.B.I. - Managing & Underwriting Ltd., Infinity Group, DNV Capital.

Will HumanTouch Surgical IPO soon?

No public IPO plans have been announced for HumanTouch Surgical.

How can I track HumanTouch Surgical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HumanTouch Surgical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNetanya
Employee Range37
Year Founded2012
Last FundingNov 29, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?